SEC Filing Summary: Landec Corporation (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation on October 4, 2011. The filing reports the consolidated financial results for the first quarter of fiscal year 2012. Note: The request metadata references "LIFECORE BIOMEDICAL, INC.", but the filing text explicitly identifies the registrant as Landec Corporation.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the attached press release (Exhibit 99.1), which is incorporated by reference but not included in the provided text.
Material Changes
The filing text does not disclose specific material changes versus the prior comparable period. It only confirms the issuance of a press release announcing the Q1 FY2012 results.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, or specific risk factors. It includes a standard disclaimer stating that the information furnished in this report and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the specific financial results (revenue, net income, EPS) by reviewing the attached Press Release (Exhibit 99.1).
- Confirm the discrepancy between the request metadata (Lifecore Biomedical) and the filing registrant (Landec Corporation).
- Review the full text of the press release for any forward-looking statements or guidance not captured in this summary.